JOSEPH JANKOVIC to Dyskinesia, Drug-Induced
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Dyskinesia, Drug-Induced.
Connection Strength
5.197
-
Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia. Drugs. 2016 May; 76(7):779-87.
Score: 0.507
-
Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia. Drugs. 2016 May; 76(7):759-77.
Score: 0.507
-
Zolpidem improves tardive dyskinesia and akathisia. Mov Disord. 2013 Oct; 28(12):1748-9.
Score: 0.412
-
Tardive dyskinesia and withdrawal emergent syndrome in children. Expert Rev Neurother. 2010 Jun; 10(6):893-901.
Score: 0.336
-
Metoclopramide, an increasingly recognized cause of tardive dyskinesia. J Clin Pharmacol. 2008 Mar; 48(3):379-84.
Score: 0.286
-
Tardive gait. Clin Neurol Neurosurg. 2008 Feb; 110(2):198-201.
Score: 0.282
-
Medical management of levodopa-associated motor complications in patients with Parkinson's disease. CNS Drugs. 2007; 21(8):677-92.
Score: 0.265
-
Metoclopramide-induced tardive dyskinesia in an infant. Mov Disord. 2005 Jan; 20(1):86-9.
Score: 0.231
-
Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov Disord. 2005; 20 Suppl 11:S11-6.
Score: 0.231
-
Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy. Mov Disord. 2005; 20 Suppl 11:S3-10.
Score: 0.231
-
Tardive and idiopathic oromandibular dystonia: a clinical comparison. J Neurol Neurosurg Psychiatry. 2000 Feb; 68(2):186-90.
Score: 0.164
-
EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's Disease. J Parkinsons Dis. 2020; 10(2):543-558.
Score: 0.163
-
Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol. Am J Psychiatry. 1999 Aug; 156(8):1279-81.
Score: 0.159
-
Levodopa-induced dyskinesias treated by pallidotomy. J Neurol Sci. 1999 Aug 01; 167(1):62-7.
Score: 0.159
-
Propofol-induced dyskinesias in Parkinson's disease. Anesth Analg. 1996 Aug; 83(2):420-22.
Score: 0.129
-
Tardive syndromes and other drug-induced movement disorders. Clin Neuropharmacol. 1995 Jun; 18(3):197-214.
Score: 0.119
-
Tardive stereotypy and other movement disorders in tardive dyskinesias. Neurology. 1993 May; 43(5):937-41.
Score: 0.103
-
Cocaine-related movement disorders. Mov Disord. 1993 Apr; 8(2):175-8.
Score: 0.102
-
Tardive tremor. Mov Disord. 1992; 7(1):53-7.
Score: 0.094
-
Persistent dystonia possibly induced by flecainide. Mov Disord. 1992; 7(1):62-3.
Score: 0.094
-
Neurologic approach to drug-induced movement disorders: a study of 125 patients. South Med J. 1990 May; 83(5):525-32.
Score: 0.084
-
Sulpiride-induced tardive dystonia. Mov Disord. 1990; 5(1):83-4.
Score: 0.082
-
Tardive oculogyric crises. Neurology. 1989 Nov; 39(11):1434-7.
Score: 0.081
-
Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. Arch Intern Med. 1989 Nov; 149(11):2486-92.
Score: 0.081
-
Coexistent tardive dyskinesia and parkinsonism. Clin Neuropharmacol. 1987 Dec; 10(6):511-21.
Score: 0.071
-
Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord. 2007 Jan 15; 22(2):193-7.
Score: 0.067
-
Tardive myoclonus. Mov Disord. 1987; 2(4):307-11.
Score: 0.066
-
Switching from pergolide to pramipexole in patients with Parkinson's disease. J Neural Transm (Vienna). 2001; 108(1):63-70.
Score: 0.044
-
Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. Ann Neurol. 2010 Jul; 68(1):18-27.
Score: 0.021
-
Occupation and risk of parkinsonism: a multicenter case-control study. Arch Neurol. 2009 Sep; 66(9):1106-13.
Score: 0.020
-
Weight gain following unilateral pallidotomy in Parkinson's disease. Acta Neurol Scand. 2000 Feb; 101(2):79-84.
Score: 0.010